Furthermore, SIRT3 inhibits the activation of hepatic stellate cells (HSCs) by mediating the downstream signaling pathway of transforming growth factor-β (TGF-β)-Smad in liver fibrosis [18]. This evidence concerns the gene SIRT3 and Hepatic fibrosis.